[ Price : $8.95]
Washington Universitys (St. Louis) new associate vice chancellor and director of its new Center for Research Innovation in Busines...[ Price : $8.95]
GlaxoSmithKline reports positive results from a planned analysis of its Phase 3 BREAK-3 study involving Tafinlar (dabrafenib) in 2...[ Price : $8.95]
An FDA medical device inspection report finds that the agency conducted 3% fewer medical device quality system surveillance inspec...[ Price : $8.95]
FDA approves an Alimera Sciences NDA for Iluvien for treating diabetic macular edema in patients who have been previously treated ...[ Price : $8.95]
FDA accepts for priority review a Bristol-Myers Squibb BLA for Opdivo (nivolumab), an investigational PD-1 immune checkpoint inhib...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Establishing That a Tobacco Product Was Commercially Marketed in the United Stat...[ Price : $8.95]
A federal appeals court deals FDA a blow, ruling that it cannot short-circuit the statutory medical device reclassification proces...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on new animal drug adverse event reporting.